12 completed, 6 unknown, 3 terminated, 2 active not recruiting. 9 Not applicable, 5 Phase 2, 3 Phase 1, 3 Phase 3, 1 Phase 4.
Follow Liver Carcinoma: new trials by email Literature Review of Liver Carcinoma trials Research Report on Liver Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The CCANED-CIPHER Study: Early Cancer Detection and Treatment Response Monitoring Using AI-Based Platelet and Immune Cell Transcriptomic Profiling DiNanoQ: A multi-cancer early detection (MCED) blood test, DiNanoTrack: Therapeutic Response Monitoring Blood Test - Brest Cancer, Lung Cancer (NSCLC) | Recruiting | Javier Toledo | 6000 | 2025-12-20 | 2026-01-02 | |
| Clinical Evaluation of an Augmented Reality Intraprocedural Needle Guidance Platform for Soft Tissue Biopsy Augmented Reality Guided Biopsy, Ultrasound Guided Biopsy - Oncology, Interventional Radiology | Not applicable | Enrolling by invitation | MediView XR, Inc. | 104 | 2025-06-27 | 2025-07-02 |
| The Vanguard Study: Testing a New Way to Screen for Cancer Biospecimen Collection, Device Usage, Electronic Health Record Review - Bladder Carcinoma, Breast Carcinoma | Not applicable | Recruiting | National Cancer Institute (NCI) | 24000 | 2025-06-18 | 2026-10-06 |
| Radiofrequency-responsive Layered Double Hydroxides for Enhanced Arterial Embolization and Thermal Immunotherapy in Hepatocellular Carcinoma Liver Carcinoma | Active not recruiting | The Fourth Affiliated Hospital of Zhejiang University School of Medicine | 130 | 2024-09-11 | 2025-05-13 | |
| the Effect of Nutrition-optimized Prehabilitation on Perioperative Intervention in Primary Liver Carcinoma Nutritional optimization-led triple prehabilitation Intervention, Conventional triple prehabilitation Intervention - Hepatocellular Carcinoma, Liver Carcinoma | Not applicable | Completed | Second Affiliated Hospital, Zhejiang University, School of Medicine | 132 | 2024-05-10 | 2026-10-02 |
| Clinical Application of 18F-labeled RD2 PET/CT Imaging in the Diagnosis and Treatment of Small Liver Carcinoma 18F-RD2 - Liver Carcinoma | Not applicable | Completed | Affiliated Hospital of Jiangnan University | 30 | 2022-08-24 | 2023-01-12 |
| Ex-vivo Hypotermic Perfusion in Patients With Hepatocellular Carcinoma to Reduce the Incidence of Tumor Recurrence Hypothermic Oxygented Perfusion, Static Cold Storage - Liver Carcinoma, Liver Transplant | Completed | IRCCS Azienda Ospedaliero-Universitaria di Bologna | 237 | 2022-06-03 | 2025-01-30 | |
| Liver Transplantation for Unresectable GIST Liver Metastases Liver Transplantation - Liver Diseases, Liver Cancer | Not applicable | Unknown | Hospital Universitario Virgen de la Arrixaca | 50 | 2022-05-01 | 2022-03-11 |
| A Phase 1, Single-arm, Open-label, Dose-escalation Study of JWATM204 as T Cell-targeted Immunotherapy in the Treatment Amongst Subjects With Advanced Hepatocellular Carcinoma CAR-GPC3 T cells - Liver Carcinoma, Hepatic Cell Carcinoma | Phase 1 | Unknown | Shanghai Ming Ju Biotechnology Co., Ltd. | 20 | 2022-03-24 | 2024-01-02 |
| Validation Study on the Removal of EpCAM-positive Tumour Cells From Blood Collected During Tumour Surgery Using Catumaxomab/Catuvab Device CATUVAB - Bladder Carcinoma, Prostate Tumor | Not applicable | Completed | Lindis Bloodcare GmbH | 136 | 2022-02-15 | 2025-01-23 |
| Radiotherapy With Iron Oxide Nanoparticles (SPION) on MR-Linac for Primary & Metastatic Hepatic Cancers Ferumoxytol injection - Liver Neoplasms, Hepatic Cirrhosis | Unknown | Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) | 40 | 2020-11-19 | 2024-01-31 | |
| Durvalumab and Lenvatinib in Participants With Locally Advanced and Metastatic Hepatocellular Carcinoma ( Dulect2020-1 ) Durvalumab Injection, Lenvatinib 4 MG - Liver Carcinoma, Liver Transplant; Complications | Not applicable | Unknown | RenJi Hospital | 20 | 2020-09-19 | 2020-09-22 |
| Gadolinium Contrast-enhanced Abbreviated MRI (AMRI) vs. Standard Ultrasound for Hepatocellular Carcinoma (HCC) Surveillance in Patients With Cirrhosis Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid - Liver Cancer, Liver Cirrhoses | Phase 4 | Completed | University of California, San Diego | 79 | 2018-04-27 | 2026-02-12 |
| AFP Model and Liver Transplantation. Liver transplantation - Liver Carcinoma, Liver Transplant Disorder | Completed | Austral University, Argentina | 1200 | 2017-11-11 | 2018-12-19 | |
| Biospecimen Collection in Identifying Genetic Changes in Patients With Breast, Prostate, Colorectal, Liver, or Kidney Cancer or Multiple Myeloma Undergoing Surgery Biospecimen Collection, Laboratory Biomarker Analysis - Breast Carcinoma, Colon Carcinoma | Suspended | National Cancer Institute (NCI) | 2400 | 2017-02-07 | 2026-05-13 | |
| Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) Adavosertib, Afatinib, Afatinib Dimaleate - Advanced Lymphoma, Advanced Malignant Solid Neoplasm | Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 6452 | 2015-08-17 | 2026-10-22 |
| Feasibility 3D Perfusion Ultrasound for Liver Cancer SABR Planning and Response Evaluation perflutren lipid microspheres, 3D ultrasound - Liver Cancer, Liver Tumor | Not applicable | Completed | Stanford University | 11 | 2014-11-18 | 2023-07-11 |
| CIRSE Registry for SIR-Spheres Therapy Yttrium-90 loaded SIR-Spheres microspheres, QLQ-C30 with HCC module - Liver Carcinoma | Completed | Cardiovascular and Interventional Radiological Society of Europe | 1051 | 2014-11-01 | 2026-05-14 | |
| Analysis of Body Composition in Patients With Hepatocellular Carcinoma in Radioablation HCC under treatment with radioablation - Liver Carcinoma | Not applicable | Withdrawn | Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | 2012-12-01 | 2016-06-08 | |
| SorAfenib Versus RADIOEMBOLIZATION in Advanced Hepatocellular Carcinoma sorafenib, SIR-Sphere - Liver Carcinoma | Phase 3 | Completed | Assistance Publique - Hôpitaux de Paris | 496 | 2011-12-01 | 2017-01-16 |
Showing 20 of 28. Sign in to see all of them.
Carcinoma, Hepatocellular (28) · Liver Neoplasms (7) · Prostatic Neoplasms (5) · Carcinoma, Renal Cell (4) · Colonic Neoplasms (4) · Ovarian Neoplasms (4) · Pancreatic Neoplasms (4) · Stomach Neoplasms (4) · Breast Neoplasms (3) · Colorectal Neoplasms (3) · Esophageal Neoplasms (3) · Lung Neoplasms (3) · Urinary Bladder Neoplasms (3) · Carcinoma, Non-Small-Cell Lung (2) · Endometrial Neoplasms (2)
Adenocarcinoma (28) · Carcinoma (28) · Digestive System Diseases (28) · Digestive System Neoplasms (28) · Neoplasms by Histologic Type (28) · Neoplasms by Site (28) · Neoplasms, Glandular and Epithelial (28) · Liver Diseases (27) · Neoplasms (26) · Liver Neoplasms (21) · Gastrointestinal Diseases (7) · Colonic Diseases (6) · Female Urogenital Diseases (6) · Female Urogenital Diseases and Pregnancy Complications (6) · Gastrointestinal Neoplasms (6)
Sorafenib (3) · Specimen Handling (3) · Liver Transplantation (2) · 2-(3-(2-(1-isopropyl-3-methyl-1H-1,2-4-triazol-5-yl)-5,6-dihydrobenzo(f)imidazo(1,2-d)(1,4)oxazepin-9-yl)-1H-pyrazol-1-yl)-2-methylpropanamide (1) · 2C4 antibody (1) · AVE1642 (1) · AZD4547 (1) · Ado-Trastuzumab Emtansine (1) · Afatinib (1) · Anthropometry (1) · Biopsy (1) · CT-P6 (1) · Crizotinib (1) · Dasatinib (1) · Disulfides (1)
National Cancer Institute (NCI) (3) · Stanford University (3) · Affiliated Hospital of Jiangnan University (1) · Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) (1) · Assistance Publique - Hôpitaux de Paris (1) · Austral University, Argentina (1) · Cardiovascular and Interventional Radiological Society of Europe (1) · Hospital Universitario Virgen de la Arrixaca (1) · IRCCS Azienda Ospedaliero-Universitaria di Bologna (1) · Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran (1) · Javier Toledo (1) · Lindis Bloodcare GmbH (1) · MediView XR, Inc. (1) · National Taiwan University Hospital (1) · PD Dr. med. Matthias Dollinger (1)
United States (9) · China (5) · France (3) · Argentina (2) · Germany (2) · Austria (1) · Canada (1) · Guam (1) · Italy (1) · Mexico (1) · Nigeria (1) · Puerto Rico (1) · Spain (1) · Taiwan (1) · United Kingdom (1)
Aldo Torre Delgadillo, M.D. M.Sc (1) · Alexander Kirichenko, MD, PhD (1) · Christophe Duvoux, MD (1) · Claude B Sirlin, MD (1) · Daniel T Chang (1) · Daniel T. Chang (1) · Hao Feng, MD., Ph.D. (1) · Haruka Itakura (1) · Javier Toledo, Medical Degree (1) · Jian-jun Zhang, MD (1) · Keith T Flaherty (1) · Markus Heiss, MD (1) · Matteo Ravaioli, MD (1) · Michelle Bennett (1)
PMID 19192962, PMID 25064436, PMID 25472660, PMID 26586415, PMID 29107679, PMID 32319960, PMID 32463741, PMID 32602828, PMID 32959085, PMID 33040420, PMID 33048619, PMID 33217193, PMID 34059326, PMID 34485882, PMID 35133871, PMID 35138919, PMID 35360522, PMID 36270925, PMID 36351402, PMID 36593888, PMID 36914788, PMID 37053535, PMID 37322121, PMID 37934000, PMID 38270476, PMID 38321223, PMID 38591867, PMID 39666929, PMID 39693587, PMID 39913886, PMID 40865033, PMID 41066729, PMID 41859477, PMID 42203908, PMID 42571808
P30CA015704 (1), U10CA180820 (1), U24CA196172 (1), UG1CA286954 (1)